跳至主要内容
临床试验/JPRN-UMIN000004937
JPRN-UMIN000004937尚未招募未知

Assessment of antithrombic agents for endoscopic procedure using biopsy forceps - ASAMA-study

Shinshu University School of Medicine0 个研究点目标入组 1,500 人开始时间: 2011年2月1日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
1,500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)without agreement 2)PT-INR>3.0 in warfarin taking patients(within 1 Month before procudere) 3)taking dual antiplatelet therapy(both aspirin and thienopyridine delivatives)(patients under discontinuation of thienopyridine delivatives before biopsy procedure can be enrolled). 4)receiving both anticoagulant and antiplatelet therapy(patients with discontinuation of antiplatelet agents or warfarin before biopsy procedure can be enrolled). 5)taking antiplatelet agents other than aspirin or thienopyridine derivatives. 6)within 12months after drug eluting stent placement. 7)taking warfarin for DVT. 8)other serious conditions, pregnency, overt bleeding tendency.

研究者

相似试验

Assessment of antithrombic agents for endoscopic... | 临床试验